Key facts
- It has raised $23.5M; the latest was Secondary Transaction - Private in Feb 2025.
- Notable investors include University of Toronto, Crosslink Capital, MaRS Investment Accelerator Fund, Golden Ventures, Radical Ventures — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Medchart
- ·The full record, as it builds
Funding rounds
No funding rounds for Medchart are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Medchart
Developer of a privacy-compliant platform designed to automate medical record release and consent capture. The company's platform simplifies identity verification, payment collection, and patient matching, enabling healthcare providers to efficiently handle record release requests while ensuring regulatory compliance.
- Sector
- Healthcare
- HQ
- Coppell, TX, United States
- Founded
- 2015
- Employees
- 138
- Website
- medchart.com/
- Ownership
- Privately Held (backing)
Medchart doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medchart shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medchart in its N-PORT filings yet. We sweep new filings monthly.